Kohlberg Kravis Roberts & Co »

Biomarin Pharma Inc convertible/ shares owned by Kohlberg Kravis Roberts & Co

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Kohlberg Kravis Roberts & Co from 13F filings

Historical chart of Kohlberg Kravis Roberts & Co investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Kohlberg Kravis Roberts & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Kohlberg Kravis Roberts & Co

Quarter filed Position value Share count Share price at filing
2024-06-30 $8.9M 9.0M 0.99
2024-03-31 $222k 225k 0.98
2023-12-31 $222k 225k 0.99
2023-09-30 $219k 225k 0.97

More positions owned by Kohlberg Kravis Roberts & Co

Brightspring Health Svcs (BTSG)
Bridgebio Pharma (BBIO)
Brightview Holdings (BV)
Jetblue Airways Corp Note 0.500% 4/0 (Principal)
Propertyguru Group Ord Shs (PGRU)
Ncl Corp Note 1.125% 2/1 (Principal)
Kkr Real Estate Finance Trust (KREF)
Realogy Grp Llc/realogy Note 0.250% 6/1 (Principal)
Madison Square Grdn Sprt Cor Cl A (MSGS)
Marriott Vacations Worldwide Note 1/1 (Principal)
Doordash Cl A (DASH)
Bausch Health Companies (BHC)
Fs Kkr Capital Corp (FSK)
Cable One Note 3/1 (Principal)
Ishares Tr Iboxx Inv Cp Etf (LQD)

View all positions for Kohlberg Kravis Roberts & Co

Top funds holding Biomarin Pharma Inc convertible/

Osterweis Capital Management
Aviva
Piper Jaffray & Co.
State Street Corporation
Branch Banking & Trust Company
Kohlberg Kravis Roberts & Co
Palisade Capital Management
Water Island Capital
Macquarie Group
Morgan Stanley
Prospector Partners
Russell Investments
Fox Hill Wealth Management

View all funds holding Biomarin Pharma Inc convertible/